KEGG: cjd:JJD26997_0180
The UPF0059 membrane protein JJD26997_0180 is a membrane-associated protein from Campylobacter jejuni subspecies doylei (strain ATCC BAA-1458/RM4099/269.97). This protein belongs to the UPF0059 family of membrane proteins, which are widely distributed across bacterial species but remain functionally uncharacterized, hence the "UPF" (Uncharacterized Protein Family) designation .
The protein consists of 187 amino acids and has a unique sequence characterized by hydrophobic regions consistent with transmembrane domains. Its complete amino acid sequence is: MDFYSLIFLSCALGMDAFAVSLCKSFSVKKLHLKHYLIVGIYFGGFQALMPTIGYFIGITFASFIASIDH WIAFILLLSIGLKMIKESLENENSNSAKQFGFKTMLALAIATSIDALAVGVSFAFLNVNLLLAIFLIGIITFILCIIALKIGNKFGIYLKNKAELLGGLVLIILGVKILIEHLFFD .
While the specific function of this protein remains to be fully elucidated, membrane proteins in C. jejuni generally play crucial roles in various cellular processes including adhesion to host cells, transport of molecules across the membrane, and interaction with the host immune system . For instance, other membrane proteins in C. jejuni such as PorA (Major Outer Membrane Protein) are involved in ion transport and adhesion to intestinal mucosa .
Unlike the well-characterized PorA (MOMP) of C. jejuni, which exists in multiple conformational forms including a folded monomer (35 kDa), denatured monomer (45 kDa), and native trimer (120-140 kDa), the UPF0059 membrane protein is smaller, with its 187 amino acids corresponding to approximately 20 kDa .
PorA consists of 18 β-strands connected by short periplasmic turns and nine external loops, with the external loops being antigenically variable . In contrast, sequence analysis of UPF0059 membrane protein suggests it likely adopts a different structural organization with multiple transmembrane segments characteristic of integral membrane proteins.
While PorA has well-documented pore-forming activities and roles in adhesion, the UPF0059 membrane protein's function remains largely speculative based on its sequence characteristics. The amino acid composition of UPF0059 suggests multiple hydrophobic regions that likely span the membrane, interspersed with charged residues that may be involved in protein-protein interactions or substrate recognition .
For the expression of recombinant UPF0059 membrane protein from C. jejuni, several expression systems have proven effective for similar membrane proteins:
E. coli expression system: This is often the first choice due to its simplicity, rapid growth, and high protein yields. For membrane proteins like UPF0059, E. coli strains specifically engineered for membrane protein expression (such as C41/C43 or Lemo21) may be preferable .
Yeast expression systems: Organisms like Saccharomyces cerevisiae or Pichia pastoris can provide a eukaryotic environment with proper protein folding machinery while maintaining relatively high yields .
Baculovirus expression system: This insect cell-based system offers advantages for complex membrane proteins that require specific post-translational modifications or folding assistance .
Mammalian cell expression systems: Though more complex and expensive, these systems may be necessary if specific mammalian-type modifications are required for proper folding or function .
The choice of expression tag (such as GST fusion as used with other C. jejuni membrane proteins) can significantly impact solubility and purification efficiency. For instance, GST-fusion proteins have been successfully used with PorA from C. jejuni .
Based on comparative analysis with other bacterial membrane proteins and the pathogenesis mechanisms of C. jejuni, UPF0059 membrane protein may participate in several aspects of bacterial virulence:
Adhesion and colonization: Like other membrane proteins in C. jejuni such as the major outer membrane protein (MOMP) and CadF (a 37-kDa fibronectin-binding protein), UPF0059 might be involved in adhesion to host cell membranes or extracellular matrix proteins, which is considered an essential primary event in pathogenesis .
Membrane transport: The protein's predicted transmembrane domains suggest it may function as a transporter for ions, nutrients, or antimicrobial compounds, potentially contributing to bacterial survival in the host environment.
Immune evasion: Bacterial membrane proteins often interact with the host immune system. The UPF0059 protein could potentially contribute to immune evasion strategies or modulation of host responses.
Environmental sensing: The protein might participate in sensing environmental cues within the host, contributing to adaptive responses during infection.
Research addressing these potential functions would require experimental approaches including gene knockout studies, adhesion assays with host cells, transport studies, and immunological investigations similar to those employed for PorA and other membrane proteins .
Investigating the immunogenic properties of UPF0059 membrane protein requires a systematic approach similar to that used for other C. jejuni antigens like PorA:
The recombinant protein should be tested in both native and denatured forms, as the conformational state significantly affects immunogenicity and protective efficacy, as demonstrated with MOMP from C. jejuni . A comprehensive immunogenicity assessment would involve both humoral (antibody) and cellular immune responses, as both contribute to protection against C. jejuni.
Identifying protein-protein interactions involving UPF0059 membrane protein requires specialized techniques suitable for membrane proteins:
Crosslinking studies: Chemical crosslinkers can capture transient protein interactions in their native membrane environment before solubilization and identification by mass spectrometry.
Pull-down assays: Using the recombinant UPF0059 protein as bait (similar to how GST-PorA fusion proteins have been used) , potential binding partners from bacterial or host cell lysates can be captured and identified.
Bacterial two-hybrid systems: Modified two-hybrid systems designed for membrane proteins can identify potential interaction partners by screening libraries of C. jejuni proteins.
Co-immunoprecipitation: Using antibodies against UPF0059 to precipitate the protein along with its binding partners from solubilized membrane preparations.
Ligand-binding immunoblotting assays: Similar to the approach used for identifying the adhesion properties of MOMP and other C. jejuni outer membrane proteins to INT 407 cell membranes and fibronectin .
Surface plasmon resonance: To characterize binding kinetics and affinities between UPF0059 and potential interacting partners identified through other methods.
When interpreting results, it's important to consider that membrane protein interactions can be affected by detergents used in solubilization, as observed with MOMP when isolated under native conditions versus in the presence of SDS .
Purification and Storage Protocol:
Extraction methods:
Purification strategies:
Affinity chromatography using tags (His-tag or GST-tag) as the primary purification step
Size exclusion chromatography to separate different oligomeric states and remove aggregates
Ion exchange chromatography as a polishing step
Buffer optimization:
Storage conditions:
Quality control checks:
SDS-PAGE to verify purity
Circular dichroism to assess secondary structure
Dynamic light scattering to check for aggregation
Functional assays where possible
It's worth noting that membrane proteins like UPF0059 often require customized conditions, and optimization may be necessary for each specific application.
Verifying the structural integrity of membrane proteins is critical for functional studies and requires multiple complementary techniques:
The importance of structural integrity assessment is highlighted by studies of other C. jejuni membrane proteins like MOMP, where the protein isolated under native conditions retained partial ability to inhibit bacterial attachment to INT 407 cell membranes, while this ability was completely lost when the protein was isolated in the presence of SDS .
Control Table for Immunological Experiments:
When conducting animal immunization studies, it's important to include controls similar to those used in studies of PorA, where mice given phosphate-buffered saline served as controls to assess the protective efficacy of the vaccine against heterologous strains .
Designing experiments to elucidate the function of uncharacterized membrane proteins requires a multi-faceted approach:
Genomic context analysis:
Examine neighboring genes for functional clues
Identify conserved gene clusters across bacterial species
Analyze regulation patterns and promoter regions
Sequence-based predictions:
Identify conserved domains and motifs
Conduct hydropathy analysis to predict transmembrane regions
Perform homology modeling if structural templates exist
Gene knockout/knockdown studies:
Generate UPF0059 deletion mutants in C. jejuni
Assess phenotypic changes in growth, stress response, and virulence
Conduct complementation studies to confirm genotype-phenotype relationships
Protein localization:
Confirm membrane localization using fractionation techniques
Determine topology using reporter fusions or accessibility assays
Assess distribution patterns during different growth phases
Interaction studies:
Identify binding partners using techniques described in section 2.3
Characterize protein-lipid interactions
Test interactions with host cell components
Functional assays based on predictions:
If transport function is suspected, conduct uptake assays with various substrates
For potential adhesins, perform adhesion assays to host cells or ECM components
Test involvement in stress response through challenge experiments
Structural studies:
Attempt crystallization for X-ray crystallography
Consider cryo-EM for structural determination
Use NMR for dynamic studies of smaller fragments
Similar approaches have been successfully employed with other C. jejuni membrane proteins, such as the investigation of MOMP and CadF in adhesion to INT 407 cell membranes and fibronectin .
Based on experiences with other C. jejuni membrane proteins, particularly PorA (MOMP), the UPF0059 membrane protein has several potential applications in vaccine development:
As a vaccine antigen: If sufficiently immunogenic and conserved across strains, UPF0059 could serve as a component in subunit vaccines. Research with PorA has demonstrated that recombinant membrane proteins from C. jejuni can provide appreciable protection (29-43%) against colonization with heterologous serotypes when delivered with appropriate adjuvants .
As an adjuvant carrier: The protein could potentially be used as a carrier for poorly immunogenic antigens or epitopes from other C. jejuni proteins.
In epitope mapping studies: Identifying immunodominant regions of UPF0059 could contribute to rational design of multi-epitope vaccines targeting conserved regions of different membrane proteins.
For serotype-independent protection: Since immunity to C. jejuni appears to be serotype-specific in humans, membrane proteins with conserved regions like UPF0059 might provide broader protection across multiple serotypes .
To advance this research, similar approaches to those used with PorA would be valuable, including:
Oral immunization studies in animal models
Assessment of both serum and intestinal lavage fluid antibodies
Protection studies against colonization with homologous and heterologous strains
Combination with appropriate mucosal adjuvants such as modified heat-labile enterotoxin of E. coli
Challenge-Solution Matrix for Membrane Protein Research:
| Challenge | Description | Solutions |
|---|---|---|
| Protein expression | Low yields, inclusion body formation, toxicity to host | - Use specialized expression strains (C41/C43) - Employ fusion partners that enhance solubility - Consider cell-free expression systems - Optimize codon usage for expression host |
| Protein purification | Detergent selection, maintaining native fold, aggregation | - Screen multiple detergents systematically - Use detergent-stable affinity tags - Employ lipid nanodiscs or amphipols - Consider native purification approaches |
| Structural characterization | Difficulty in crystallization, size limitations for NMR | - Use lipidic cubic phase for crystallization - Consider cryo-EM for larger complexes - Employ hydrogen-deuterium exchange mass spectrometry - Use computational modeling alongside experimental data |
| Functional assays | Unknown function, lack of activity assays | - Develop binding assays to potential partners - Use phenotypic analysis of knockout mutants - Conduct comparative studies with related proteins - Employ label-free interaction analysis |
| Immunological studies | Conformational epitopes, adjuvant selection | - Compare native vs. denatured forms - Test multiple adjuvant formulations - Consider virus-like particle display systems - Evaluate both systemic and mucosal immune responses |
| Reproducibility | Batch-to-batch variation, detergent effects | - Implement rigorous quality control protocols - Standardize purification procedures - Document detergent lots and preparation methods - Perform functional validation of each preparation |
Researchers studying MOMP from C. jejuni have encountered similar challenges, particularly related to maintaining native conformation. For instance, MOMP's ability to inhibit bacterial attachment was partially retained when isolated under native conditions but completely lost when isolated with SDS , highlighting the importance of purification conditions for functional studies.